Two Sigma Advisers
BNGO icon

Two Sigma Advisers’s Bionano Genomics BNGO Stock Holding History

Two Sigma Advisers’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-283
Closed -$18.9K – 2456
2024
Q1 		$18.9K Sell
283
-253
-47% -$18.9K ﹤0.01% 2406
2023
Q4 		$60.8K Buy
+536
New +$56K ﹤0.01% 2383
2022
Q1 		– Sell
-132
Closed -$236K – 2741
2021
Q4 		$236K Sell
132
-304
-70% -$813K ﹤0.01% 2230
2021
Q3 		$1.44M Buy
436
+375
+615% +$1.31M ﹤0.01% 1429
2021
Q2 		$267K Buy
+61
New +$241K ﹤0.01% 2179

Other funds holding BNGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Two Sigma Advisers's BNGO Position: Q2 2024 in Review

Two Sigma Advisers sold out of Bionano Genomics (BNGO) in Q2 2024, closing a stake of 283 shares — an estimated $18.9K sold.

Two Sigma Advisers first reported a position in BNGO in Q2 2021 and held it in 5 quarters. The position peaked at $1.44M in Q3 2021. 53 funds tracked by Wall St. Rank hold BNGO as of Q2 2024.

  • Two Sigma Advisers reported no remaining Bionano Genomics position as of Q2 2024 after selling out during the quarter.
  • Two Sigma Advisers sold 283 Bionano Genomics shares in Q2 2024, an estimated $18.9K.
  • Two Sigma Advisers first reported a position in Bionano Genomics in Q2 2021 and held it in 5 quarters.
  • Two Sigma Advisers's Bionano Genomics position peaked at $1.44M in Q3 2021.
  • 53 funds tracked by Wall St. Rank held Bionano Genomics as of Q2 2024.

Based on Two Sigma Advisers's 13F filing for Q2 2024, filed 14 Aug 2024.